LAVA Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LVTX and other ETFs, options, and stocks.About LVTX
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
CEOStephen Allen Hurly
CEOStephen Allen Hurly
Employees34
Employees34
HeadquartersUtrecht, Noord-Brabant
HeadquartersUtrecht, Noord-Brabant
Founded2016
Founded2016
Employees34
Employees34
LVTX Key Statistics
Market cap34.72M
Market cap34.72M
Price-Earnings ratio-1.27
Price-Earnings ratio-1.27
Dividend yield—
Dividend yield—
Average volume25.54K
Average volume25.54K
High today$1.32
High today$1.32
Low today$1.29
Low today$1.29
Open price$1.31
Open price$1.31
Volume21.77K
Volume21.77K
52 Week high$2.53
52 Week high$2.53
52 Week low$0.8502
52 Week low$0.8502
People also own
Based on the portfolios of people who own LVTX. This list is generated using Robinhood data, and it’s not a recommendation.